Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-85,545
Closed -$581K 1804
2025
Q3
$581K Buy
85,545
+25,496
+42% +$211K 0.01% 1214
2025
Q2
$818K Buy
+60,049
New +$567K 0.02% 1028
2024
Q2
Sell
-25,995
Closed -$267K 1672
2024
Q1
$267K Buy
25,995
+3,258
+14% +$24.1K 0.02% 1008
2023
Q4
$188K Buy
+22,737
New +$163K 0.02% 1016

Other funds holding LFMD

Y-Intercept (HK)'s LFMD Position: Q4 2025 in Review

Y-Intercept (HK) sold out of LifeMD (LFMD) in Q4 2025, closing a stake of 85,545 shares — an estimated $581K sold.

Y-Intercept (HK) first reported a position in LFMD in Q4 2023 and held it in 4 quarters. The position peaked at $818K in Q2 2025. 104 funds tracked by Wall St. Rank hold LFMD as of Q4 2025.

  • Y-Intercept (HK) reported no remaining LifeMD position as of Q4 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 85,545 LifeMD shares in Q4 2025, an estimated $581K.
  • Y-Intercept (HK) first reported a position in LifeMD in Q4 2023 and held it in 4 quarters.
  • Y-Intercept (HK)'s LifeMD position peaked at $818K in Q2 2025.
  • 104 funds tracked by Wall St. Rank held LifeMD as of Q4 2025.

Based on Y-Intercept (HK)'s 13F filing for Q4 2025, filed 13 Feb 2026.